Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The Europe specialty generics market size reached US$ 18.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 30.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.76% during 2023-2028.

Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc. 

Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don’t require expensive and time-consuming research and development procedures. Additionally, they also don’t incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

  • Italy
  • Germany
  • France
  • United Kingdom
  • Spain
  • Rest of Europe


Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others


Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others


Breakup by Distribution Channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies
     

Competitive Landscape:

The leading players in the European specialty generics industry have also been examined in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Route of Administration, Indication, Distribution Channel, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain, Rest of Europe
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Europe Specialty Generics Market: Introduction
5   Why are Specialty Generics So Lucrative?
6   Europe Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Impact of COVID-19
    6.4    Market Breakup by Route of Administration
    6.5    Market Breakup by Indication
    6.6    Market Breakup by Distribution Channel
    6.7    Market Breakup by Region
    6.8    Market Forecast
    6.9    SWOT Analysis
        6.9.1    Overview
        6.9.2    Strengths
        6.9.3    Weaknesses
        6.9.4    Opportunities
        6.9.5    Threats
    6.10    Value Chain Analysis
    6.11    Porters Five Forces Analysis
        6.11.1    Overview
        6.11.2    Bargaining Power of Buyers
        6.11.3    Bargaining Power of Suppliers
        6.11.4    Degree of Competition
        6.11.5    Threat of New Entrants
        6.11.6    Threat of Substitutes
    6.12    Key Market Drivers and Success Factors
7   Market Breakup by Route of Administration
    7.1    Injectable
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Others
        7.3.1    Market Trends
        7.3.2    Market Forecast
8   Market Breakup by Indication
    8.1    Oncology
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Autoimmune Diseases
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Infectious Diseases
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Others
        8.4.1    Market Trends
        8.4.2    Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Specialty Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Hospital Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
10  Market Breakup by Region
    10.1    Germany
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    France
         10.2.1    Market Trends
         10.2.2    Market Forecast
    10.3   United Kingdom
         10.3.1    Market Overview
         10.3.2    Market Performance
     10.4    Spain
          10.4.1    Market Performance
          10.4.2    Market Forecast
       10.5    Others
           10.5.1    Market Trends
           10.5.2    Market Forecast
11  Competitive Landscape
    11.1    Market Structure
    11.2    Key Players

List of Figures

Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2022
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2022
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2017 & 2022
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2017 & 2022
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2017 & 2022
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2017 & 2022
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2017 & 2022
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2017 & 2022
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2017 & 2022
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion US$), 2017 & 2022
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion US$), 2023-2028
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion US$), 2017 & 2022
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion US$), 2023-2028
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion US$), 2017 & 2022
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion US$), 2023-2028
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 34: France: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028

List of Tables

Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2023-2028
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2023-2028
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2023-2028
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2023-2028
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The Europe specialty generics market was valued at US$ 18.3 Billion in 2022.

We expect the Europe specialty generics market to exhibit a CAGR of 8.76% during 2023-2028.

The increasing demand for specialty generics to treat chronic medical conditions, such as cancer, hemophilia, sclerosis, Inflammatory Bowel Disease (IBD), and Human Immunodeficiency Virus (HIV), is primarily driving the Europe specialty generics market.

The sudden outbreak of the COVID-19 pandemic had led to the rising focus on the coronavirus infection vaccine and drugs resulting in the delay in the R&D activities pertaining to specialty generic drugs across several European nations.

Based on the route of administration, the Europe specialty generics market can be categorized into injectables, oral, and others. Currently, injectables account for the majority of the total market share.

Based on the indication, the Europe specialty generics market has been segregated into oncology, autoimmune diseases, infectious diseases, and others. Among these, oncology currently holds the largest market share.

Based on the distribution channel, the Europe specialty generics market can be bifurcated into retail pharmacies, specialty pharmacies, and hospital pharmacies. Currently, retail pharmacies exhibit a clear dominance in the market.

On a regional level, the market has been classified into Italy, Germany, France, United Kingdom, Spain, and Rest of Europe, where Italy currently dominates the Europe specialty generics market.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2699

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4